These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9634494)

  • 1. Tumor pH: implications for treatment and novel drug design.
    Gerweck LE
    Semin Radiat Oncol; 1998 Jul; 8(3):176-82. PubMed ID: 9634494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
    Gerweck LE; Seetharaman K
    Cancer Res; 1996 Mar; 56(6):1194-8. PubMed ID: 8640796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics.
    Kozin SV; Shkarin P; Gerweck LE
    Cancer Res; 2001 Jun; 61(12):4740-3. PubMed ID: 11406545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy.
    Raghunand N; Altbach MI; van Sluis R; Baggett B; Taylor CW; Bhujwalla ZM; Gillies RJ
    Biochem Pharmacol; 1999 Feb; 57(3):309-12. PubMed ID: 9890558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH and therapy of human cancers.
    Evelhoch JL
    Novartis Found Symp; 2001; 240():68-80; discussion 80-4, 152-3. PubMed ID: 11727937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH and chemotherapy.
    Raghunand N; Gillies RJ
    Novartis Found Symp; 2001; 240():199-211; discussion 265-8. PubMed ID: 11727930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours.
    Bhujwalla ZM; McCoy CL; Glickson JD; Gillies RJ; Stubbs M
    Br J Cancer; 1998 Sep; 78(5):606-11. PubMed ID: 9744499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intracellular pH control and relationship to cytotoxicity of chlorambucil and vinblastine.
    Parkins CS; Chadwick JA; Chaplin DJ
    Br J Cancer Suppl; 1996 Jul; 27():S75-7. PubMed ID: 8763851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate.
    Gillies RJ; Liu Z; Bhujwalla Z
    Am J Physiol; 1994 Jul; 267(1 Pt 1):C195-203. PubMed ID: 8048479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.
    Gerweck LE; Kozin SV; Stocks SJ
    Br J Cancer; 1999 Feb; 79(5-6):838-42. PubMed ID: 10070878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics.
    Gerweck LE; Vijayappa S; Kozin S
    Mol Cancer Ther; 2006 May; 5(5):1275-9. PubMed ID: 16731760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphate-analogue probe of red cell pH using phosphorus-31 nuclear magnetic resonance.
    Labotka RJ; Kleps RA
    Biochemistry; 1983 Dec; 22(26):6089-95. PubMed ID: 6661429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient.
    Kozin SV; Gerweck LE
    Br J Cancer; 1998 May; 77(10):1580-5. PubMed ID: 9635832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
    Sun X; Zhang G; Wu Z
    Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid.
    Griffiths JR; McIntyre DJ; Howe FA; Stubbs M
    Novartis Found Symp; 2001; 240():46-62; discussion 62-7, 152-3. PubMed ID: 11727936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.
    Indulkar AS; Box KJ; Taylor R; Ruiz R; Taylor LS
    Mol Pharm; 2015 Jul; 12(7):2365-77. PubMed ID: 25984769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hypoxia and low pH on the cytotoxicity of chlorambucil.
    Skarsgard LD; Chaplin DJ; Wilson DJ; Skwarchuk MW; Vinczan A; Kristl J
    Int J Radiat Oncol Biol Phys; 1992; 22(4):737-41. PubMed ID: 1544846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.